Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

Arcturus Therapeutics (ARCT) Insider Trading & Ownership

Arcturus Therapeutics logo
$6.69 -0.34 (-4.84%)
Closing price 05/19/2026 04:00 PM Eastern
Extended Trading
$6.50 -0.19 (-2.90%)
As of 06:27 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Arcturus Therapeutics (NASDAQ:ARCT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
17.80%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
2
Amount Of
Insider Selling
(Last 3 Years)
$3.85M
Get ARCT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Arcturus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ARCT Insider Buying and Selling by Quarter

Arcturus Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/15/2024Sell12,000$20.76$249,120.00  
6/5/2024Sell114$45.00$5,130.00  
6/3/2024Sell26,000$40.01$1,040,260.00  
3/25/2024Sell17,435$35.02$610,573.70  
3/19/2024Sell8,565$35.01$299,860.65  
11/1/2023Sell5,000$18.72$93,600.00  
10/2/2023Sell5,000$25.61$128,050.00  
9/1/2023Sell5,000$31.45$157,250.00  
7/14/2023Sell6,968$35.00$243,880.00  
7/14/2023Sell25,000$35.01$875,250.00  
Read now. Do not delete. You’ve been warned. (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
7/3/2023Sell5,000$28.75$143,750.00  
(Data available from 1/1/2013 forward)

ARCT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Arcturus Therapeutics includes Keith C Kummerfeld, and Pad Chivukula. Learn more on insiders at ARCT.

17.80% of Arcturus Therapeutics stock is owned by insiders. Learn more on ARCT's insider holdings.

The following insider sold ARCT shares in the last 24 months: Pad Chivukula ($1,294,510.00).

Insiders have sold a total of 38,114 Arcturus Therapeutics shares in the last 24 months for a total of $1,294,510.00 sold.

Arcturus Therapeutics Active Insiders



This page (NASDAQ:ARCT) was last updated on 5/20/2026 by MarketBeat.com Staff.
From Our Partners